Bonum Therapeutics
Signal active
Organization
Contact Information
Overview
Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary therapeutic area of focus—as well as metabolic diseases, immunology, and pain management.
About
Industries
Biotechnology, Life Science, Medical, Therapeutics
Founded
2021
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Bonum Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $1.5B in funding across 16 round(s). With a team of 11-50 employees, Bonum Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Bonum Therapeutics, raised $93.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
6
Lead Investors
0
Total Funding Amount
$93.0M
Details
1
Bonum Therapeutics has raised a total of $93.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 93.0M |
Investors
Bonum Therapeutics is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Digitalis Ventures | - | FUNDING ROUND - Digitalis Ventures | 93.0M |
| Monique Schiersing | - | FUNDING ROUND - Monique Schiersing | 93.0M |
| Bonum Therapeutics | - | FUNDING ROUND - Bonum Therapeutics | 93.0M |
| Roche Venture Fund | - | FUNDING ROUND - Roche Venture Fund | 93.0M |
Recent Activity
There is no recent news or activity for this profile.